Markets
← Back to Stocks
ELV
ELEVANCE HEALTH INC
Health Care · Managed Health Care
$291.14
-1.13%
Vol: 0.0M
Araverus Market Read
Thursday, March 19, 2026
Elevance Health drops in after-hours on higher medical cost concerns weighing on 2026 profit outlook.
Elevance Health (ELV) closed at $291.63 and declined $1.68 in after-hours trading after guiding 2026 profit below Wall Street expectations due to persistent higher medical costs. The health insurer reaffirmed FY26 adjusted EPS of at least $25.50 versus consensus $23.86. Mizuho lowered price target to $350 from $413, though Barclays maintained Buy rating amid CMS regulatory challenges.
Price 50d 200d
Previous Market Reads
2 of 2 daysSector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$64.3B
P/E (TTM)11.5
Forward P/E9.9
Beta0.47
Div Yield233.00%
Prev Close$294.48
RSI (14-Day)
34Neutral
0305070100
52-Week Range
$273.71$291.14$458.75
From High-36.5%
From Low+6.4%
Moving Averages
50d SMA
$330.91-12.0%
200d SMA
$328.74-11.4%
Price below 200d MA — bearish structure.
Returns
1W
+1.1%
1M
-15.4%
3M
-16.8%
6M
-4.5%
1Y
-31.8%
YTD
-17.3%
Volume
Today45K
20d Avg2.4M
Ratio0.02x